These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1659431)

  • 21. [Accumulation of the infectious virus and the viral antigen during the multiplication of the hepatitis A virus in an embryonic kidney cell culture of the rhesus macaque (FRhK-4)].
    Kusov IuIu; Fleer GP; Zavodova TI; Panina LI; Donets MA
    Vopr Virusol; 1987; 32(3):307-12. PubMed ID: 2445108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis A-virus in cell culture. IV. Comparison of cell-culture-produced HAV with stool-derived HAV in diagnostic test systems.
    Flehmig B; Pfisterer M; Vallbracht A
    Med Microbiol Immunol; 1984; 172(4):207-13. PubMed ID: 6325856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Further evaluation of a live hepatitis A vaccine in marmosets.
    Provost PJ; Banker FS; Wadsworth CW; Krah DL
    J Med Virol; 1991 Aug; 34(4):227-31. PubMed ID: 1658214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary study of attenuated live hepatitis A vaccine (H2 strain) in humans.
    Mao JS; Dong DX; Zhang HY; Chen NL; Zhang XY; Huang HY; Xie RY; Zhou TJ; Wan ZJ; Wang YZ
    J Infect Dis; 1989 Apr; 159(4):621-4. PubMed ID: 2538518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Propagation and assay of hepatitis A virus in vitro.
    Siegl G; deChastonay J; Kronauer G
    J Virol Methods; 1984 Aug; 9(1):53-67. PubMed ID: 6094609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis A-virus in cell culture. V. Neutralizing antibodies against hepatitis A-virus.
    Zahn J; Vallbracht A; Flehmig B
    Med Microbiol Immunol; 1984; 173(1):9-17. PubMed ID: 6088963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous vaccination for hepatitis A and B.
    Flehmig B; Heinricy U; Pfisterer M
    J Infect Dis; 1990 May; 161(5):865-8. PubMed ID: 2157770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunologic approaches to assessing the response to inactivated hepatitis A vaccine.
    Lemon SM
    J Hepatol; 1993; 18 Suppl 2():S15-9. PubMed ID: 8182266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parameters influencing the attachment of hepatitis A virus to a variety of continuous cell lines.
    Zajac AJ; Amphlett EM; Rowlands DJ; Sangar DV
    J Gen Virol; 1991 Jul; 72 ( Pt 7)():1667-75. PubMed ID: 1649900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A simple method for clonal selection of hepatitis A virus based on recovery of virus from radioimmunofocus overlays.
    Lemon SM; Jansen RW
    J Virol Methods; 1985 Jun; 11(2):171-6. PubMed ID: 2991315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hepatitis A in Macaca fascicularis and M. arctoides infected by the Java monkey-55 strain of hepatitis A virus].
    Andzhaparidze AG; Kazachkov IuA; Balaian MS; Kusov IuIu; Poleshchuk VF
    Vopr Virusol; 1987; 32(4):440-8. PubMed ID: 2825433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of hepatitis A virus in sewage sludge by antigen capture polymerase chain reaction.
    Graff J; Ticehurst J; Flehmig B
    Appl Environ Microbiol; 1993 Oct; 59(10):3165-70. PubMed ID: 8250546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of the inactivation kinetics of hepatitis A virus in human plasma products using a simple TCID50 assay.
    Barrett PN; Meyer H; Wachtel I; Eibl J; Dorner F
    J Med Virol; 1996 May; 49(1):1-6. PubMed ID: 8732864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Simultaneous detection of IgM antibodies against the hepatitis A virus and the viral capsid antigen of Epstein-Barr virus in acute hepatitis].
    Naveau S; Delfraissy JF; Poitrine A; Poynard T; Chaput JC
    Gastroenterol Clin Biol; 1985 Feb; 9(2):109-12. PubMed ID: 2984075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Properties of a hepatitis A virus candidate vaccine strain.
    Heinricy U; Stierhof YD; Pfisterer M; Flehmig B
    J Gen Virol; 1987 Sep; 68 ( Pt 9)():2487-93. PubMed ID: 2821186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Radioimmunological determination of HAV and anti-HAV IgA in the feces of patients with acute type-A hepatitis].
    Angarano G; Coppola S; Frappampina V; Monno L; Santantonio T
    Boll Ist Sieroter Milan; 1982; 61(5):383-9. PubMed ID: 6100166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a Real-Time Cell Analysis (RTCA) Method as a Fast and Accurate Method for Detecting Infectious Particles of the Adapted Strain of Hepatitis A Virus.
    Lebourgeois S; Fraisse A; Hennechart-Collette C; Guillier L; Perelle S; Martin-Latil S
    Front Cell Infect Microbiol; 2018; 8():335. PubMed ID: 30319992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A.
    Glück R; Mischler R; Brantschen S; Just M; Althaus B; Cryz SJ
    J Clin Invest; 1992 Dec; 90(6):2491-5. PubMed ID: 1334977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indigenous anti-hepatitis A virus IgM capture ELISA for the diagnosis of hepatitis A.
    Chitambar SD; Murthy-Grewal S; Bokil M; Arankalle VA; Gore MM; Banerjee K
    Indian J Med Res; 1994 Jun; 99():243-51. PubMed ID: 8088883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and immunogenicity of live attenuated hepatitis A virus vaccine (H2 strain) in humans.
    Ran LA; Wang DZ; Duan QY; Yan TY; Liu QL; Luo YG; Yang DZ; Yang DF; Xiao Z; Xie QJ
    Chin Med J (Engl); 1993 Aug; 106(8):604-7. PubMed ID: 8222910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.